Effect of palmyra sprouts supplementation on Metabolic Status, Hormone Variables and Ovarian Morphology in Women with Polycystic Ovary Syndrome

Evaluating the impact of Nutrient Dense Supplementation enriched with Palmyra sprouts on Metabolic Status, Hormone Variables and Ovarian Morphology in Women with Polycystic Ovary Syndrome - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106425

Enrollment

128

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E70-E88- Metabolic disorders

Interventions

Intervention1: Palmyra sprouts: The supplementation intervention will be given over a duration of 90 days. Supplementation of Palmyra tuber is recommended at a dosage of up to 50-100 grams per day. Co

Eligibility

Inclusion criteria

Inclusion criteria: The participants who are diagnosed as PCOS by the physician based on rotterdam criteria

Exclusion criteria

Exclusion criteria: The participants who are pregnant and breastfeeding. The participants currently involved in fertility treatment. The participants who are allergic to roots and tubers.

Design outcomes

Primary

Measure	Time frame
The assessment of metabolic status will include Oral Glucose Tolerance Test (Fasting, 1Hour and 2Hour), Fasting insulin level, Fasting Lipid Profile (Cholesterol level, HDL and LDL).The assessment of hormone variables will include the measurement of serum testosterone, serum prolactin and thyroid hormones specifically T4 and TSH.In addition to the PCOS Panel Ovarian Morphology will be carried out through ultrasound Timepoint: These parameters will be assessed at two specific time points: at baseline (prior to the initiation of supplementation) and after 90 days of supplementation to evaluate the changes associated with the intervention.	—

Measure

Time frame

The assessment of metabolic status will include Oral Glucose Tolerance Test (Fasting, 1Hour and 2Hour), Fasting insulin level, Fasting Lipid Profile (Cholesterol level, HDL and LDL).The assessment of hormone variables will include the measurement of serum testosterone, serum prolactin and thyroid hormones specifically T4 and TSH.In addition to the PCOS Panel Ovarian Morphology will be carried out through ultrasound Timepoint: These parameters will be assessed at two specific time points: at baseline (prior to the initiation of supplementation) and after 90 days of supplementation to evaluate the changes associated with the intervention.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactAISHWARYA CV

Sri Ramachandra Institute of Higher Education and Research

cvaishwarya@sriramachandra.edu.in9884290657

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026